Safety and tolerance of liposomal amphotericin B in the treatment of invasive aspergillosis in a neutropenic adolescent
Gandemer, V.; Taque, S.; Guiguen, C.; Rambeau, M.; Sayagh, M.; Gall, E. le
Journal de Mycologie Medicale 10(2): 105-107
2000
ISSN/ISBN: 1156-5233
Accession: 003553226
This study aimed to demonstrate the safety and tolerance of liposomal amphotericin B (L-amB) in a neutropenic patient who developed severe nephrotoxicity with conventional amphotericin (C-amB) and amphotericin B lipid complex (ABLC). Seven months after allogenic bone marrow transplantation (BMT) for chronic myelogenous leukaemia, a 15-year-old boy, from France, relapsed (biphenotypic acute leukaemia).
PDF emailed within 1 workday: $29.90
Related References
Pagano, L.; Valentini, C.G.; Fianchi, L.; Caira, M. 2011: Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B? Journal of ChemoTherapy 23(1): 5-8Zhirong, Y.; Wanqing, L.; Weihua, P. 1999: Case reports. Invasive pulmonary aspergillosis in non-neutropenic patients treated with liposomal amphotericin B Mycoses 42(11-12): 679-682
Dornbusch, H.J.; Urban, C.E.; Pinter, H.; Ginter, G.; Fotter, R.; Becker, H.; Miorini, T.; Berghold, C. 1995: Treatment of invasive pulmonary aspergillosis in severely neutropenic children with malignant disorders using liposomal amphotericin B (AmBisome), granulocyte colony-stimulating factor, and surgery: report of five cases Pediatric Hematology and Oncology 12(6): 577-586
Lewis, R.E.; Albert, N.D.; Kontoyiannis, D.P. 2008: Efficacy of single-dose liposomal amphotericin B or micafungin prophylaxis in a neutropenic murine model of invasive pulmonary aspergillosis Antimicrobial Agents and ChemoTherapy 52(11): 4178-4180
Ruijgrok, E.J.; Vulto, A.G.; Van Etten, E.W. 2001: Efficacy of aerosolized amphotericin B desoxycholate and liposomal amphotericin B in the treatment of invasive pulmonary aspergillosis in severely immunocompromised rats Journal of Antimicrobial ChemoTherapy 48(1): 89-95
Walsh, T.J.; Yeldandi, V.; McEvoy, M.; Gonzalez, C.; Chanock, S.; Freifeld, A.; Seibel, N.I.; Whitcomb, P.O.; Jarosinski, P.; Boswell, G.; Bekersky, I.; Alak, A.; Buell, D.; Barret, J.; Wilson, W. 1998: Safety, Tolerance, and Pharmacokinetics of a Small Unilamellar Liposomal Formulation of Amphotericin B (AmBisome) in Neutropenic Patients Antimicrobial Agents and Chemotherapy 42(9): 2391-2398
Walsh, T.J.; Yeldandi, V.; McEvoy, M.; Gonzalez, C.; Chanock, S.; Freifeld, A.; Seibel, N.I.; Whitcomb, P.O.; Jarosinski, P.; Boswell, G.; Bekersky, I.; Alak, A.; Buell, D.; Barret, J.; Wilson, W. 1998: Safety, tolerance, and pharmacokinetics of a small unilamellar liposomal formulation of amphotericin B (AmBisome) in neutropenic patients Antimicrobial Agents and ChemoTherapy 42(9): 2391-2398
Lestner, J.M.; Howard, S.J.; Goodwin, J.; Gregson, L.; Majithiya, J.; Walsh, T.J.; Jensen, G.M.; Hope, W.W. 2010: Pharmacokinetics and pharmacodynamics of amphotericin B deoxycholate, liposomal amphotericin B, and amphotericin B lipid complex in an in vitro model of invasive pulmonary aspergillosis Antimicrobial Agents and ChemoTherapy 54(8): 3432-3441
Tortorano, A.M.; Viviani, M.A.; Fattori, L.; Cortellaro, M.; Della Volpe, A.; Langer, M. 1990: Liposomal amphotericin b in the treatment of invasive pulmonary aspergillosis ipa Journal of Cancer Research and Clinical Oncology 116(Suppl Part 1): 637
Silling Engelhardt, G.; Roos, N.; Fegeler, W.; Buechner, T. 1993: Liposomal amphotericin B in neutropenic patients with pulmonary aspergillosis Annals of Hematology 67(Suppl ): A118
Rome, A.; André, N.; Michel, A.; Coze, C.; Gentet, J.-C.; Bernard, J.-L. 2006: Successful treatment with caspofungin of an invasive candidosis resistant to liposomal amphotericin B in a neutropenic patient Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 13(12): 1556-1557
Winkler, J.; Müller, U.; Nenoff, P.; Seyfarth, H-J.; Vogtmann, M.; Borte, G.; Pönisch, W.; Kahn, T.; Wirtz, H.; Schauer, J.; Hoheisel, G. 2007: Treatment of invasive pulmonary aspergillosis in neutropenic patients by additional bronchoscopic amphotericin B instillation Respiration; International Review of Thoracic Diseases 74(6): 663-673
Matsuda, H.; Kohno, S.; Miyazaki, Y.; Mitsutake, K.; Tanaka, K.; Maesaki, S.; Iwamoto, M.; Hashimoto, A.; Kaku, M.; Koga, H. 1993: Treatment of experimental invasive pulmonary aspergillosis in rats with liposomal amphotericin B Kansenshogaku Zasshi. Journal of the Japanese Association for Infectious Diseases 67(2): 102-109
Filippou, N.; Papachristou, K.; Ilias, I.; Pefanis, A.; Papaleftheris, E.; Iliopoulos, I. 2000: Chronic necrotizing pulmonary aspergillosis in a non-neutropenic patient treated with liposomal amphotericin B Mycoses 43(7/8): 313-315
Hachem, R.Y.; Boktour, M.R.; Hanna, H.A.; Husni, R.N.; Torres, H.A.; Afif, C.; Kontoyiannis, D.P.; Raad, I.I. 2008: Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancy Cancer 112(6): 1282-1287
Becker, M.J.; de Marie, S.; Fens, M.H.A.M.; Verbrugh, H.A.; Bakker-Woudenberg, I.A.J.M. 2003: Effect of amphotericin B treatment on kinetics of cytokines and parameters of fungal load in neutropenic rats with invasive pulmonary aspergillosis Journal of Antimicrobial ChemoTherapy 52(3): 428-434
Gavaldà, J.; Martín, T.; López, P.; Gomis, X.; Ramírez, J.L.; Rodríguez, D.; Len, O.; Puigfel, Y.; Ruiz, I.; Pahissa, A. 2005: Efficacy of high loading doses of liposomal amphotericin B in the treatment of experimental invasive pulmonary aspergillosis Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 11(12): 999-1004
Mele, L.; Pagano, L.; Equitani, F.; Leone, G. 2001: Case reports. Secondary prophylaxis with liposomal amphotericin B after invasive aspergillosis following treatment for haematological malignancy Mycoses 44(5): 201-203
Streppel, M.; Bachmann, G.; Arnold, G.; Damm, M.; Stennert, E. 1999: Successful treatment of an invasive aspergillosis of the skull base and paranasal sinuses with liposomal amphotericin B and itraconazole Annals of Otology Rhinology and Laryngology 108(2): 205-207
Palacio, C.; Acebedo, G.; López, A.; Jodar, J.M. 1994: Remission of invasive sinusal and pulmonary aspergillosis with liposomal amphotericin B in a patient with chronic lymphatic leukemia following failure with conventional amphotericin Sangre 39(5): 389-392